Drug intelligence / Profile preview

2-[3-(5-mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a small molecule with the chemical formula C13H15N5O2S2 and a molecular weight of approximately 337.42 Da. It contains a thiadiazole ring with a mercapto group and is structurally related to phenylalanine derivatives. The drug has been assigned the code name PNU–107859 and is referenced as ATT in structural databases. There are no approved indications or clinical trial data available for this compound; it appears to be an experimental molecule without established pharmacological use or known mechanism of action[1][6][8]. No information on its mechanism of action or therapeutic targets has been published.

Other names: (2S)-N-methyl-3-phenyl-2-{[(5-sulfanylidene-4,5-dihydro-1,3,4-thiadiazol-2-yl)carbamoyl]amino}propanamideN-Methyl-Nalpha-[(5-thioxo-4,5-dihydro-1,3,4-thiadiazol-2-yl)carbamoyl]-L-phenylalaninamide(S)-N-Methyl-3-phenyl-2-[3-(5-thioxo-4,5-dihydro-[1,3,4]thiadiazol-2-yl)ureido]propionamide

Beyond the preview

Go deeper on 2-[3-(5-mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-[3-(5-mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide.

Explore the full profile